Skip to main content
AbbVieProduct change

AbbVie discontinued its Phase 2 solid tumor drug livmoniplimab, tested in combination with budigalimab, citing limited clinical benefit.

Source: Autobound Signal API · 112 signals tracked for AbbVie · updated

Get AbbVie's live signals in Claude or ChatGPT, or by API

AskWhat changed at AbbVie this week? Use Autobound signals for abbvie.com.

What happened

Post: "AbbVie abandons phase 2 solid tumor drug over ‘limited benefit’"

Source

RedditNov 3, 2026By u/NotGenentech

r/biotech

AbbVie abandons phase 2 solid tumor drug over ‘limited benefit’

upvotes
49
comments
14

Extracted from these lines

  • [comment u/Plenty_of_prepotente] Livmoniplimab, the phase 2 solid tumor drug in the article, was being tested in combination with AbbVie's anti-PD-1 budigalimab, even though as a single agent livmo had an overall response rate in phase 1 of 0%.

reddit.com/r/biotech/comments/1xmz093/abbvie_abandons_phase_2_solid_t...Open the source

Comments on the post

2 of 14 comments
  • “From the outside, it looks like AbbVie's oncology strategy needs a rethink. Livmoniplimab, the phase 2 solid tumor drug in the article, was being tested in combination with AbbVie's anti-PD-1 budigalimab, even though as a single agent livmo had an overall response rate in phase 1 of 0%. Why would you keep going after that, assuming you correctly included potentially responsive patients? The biolog”

    u/Plenty_of_prepotente13 points · Nov 3, 2026View

  • “No wonder their Early pipeline medical role is being moved to Chicago, discovery doesn’t know its ass from its elbow”

    u/shivaswrath1 points · Nov 4, 2026View

Extracted by Autobound

From the Signal API record
Signal
Product change

What this signalsUser posts often show product pain before it reaches reviews or churn.

Subreddit
r/biotech
Stage
Confirmed
Event date
Nov 2026

The full record

From the Signal API record

Numbers

Mentions
1

Details

Timing
Completed
Category
Discontinued
Virality
Somewhat high
Post kind
Link
Prominence
Core
Company's role
Subject
Signal category
Event

Topics and mentions

Topics

  • oncology
  • clinical trials
  • pipeline
  • biotech

Flair

  • Biotech News 📰

Products named

  • livmoniplimab
  • budigalimab

Extraction

Sentiment
Negative
Detected
Nov 3, 2026
signal_type
reddit-company
signal_subtype
productChange

Use this data

Get every Reddit signal for AbbVie and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at AbbVie this week?”

  2. Send it to your own tools

    The Signal API returns Reddit signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full reddit-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/bde3d4ca-9985-5d0a-a549-e4025b05630e returns this record as JSON. POST /v1/companies/enrich returns every signal for abbvie.com.

{
  "signal_id": "bde3d4ca-9985-5d0a-a549-e4025b05630e",
  "signal_type": "reddit-company",
  "signal_subtype": "productChange",
  "detected_at": "2026-11-03T17:20:36+00:00",
  "company": {
    "name": "AbbVie",
    "domain": "abbvie.com"
  },
  "data": {
    "nsfw": false,
    "stage": "confirmed",
    "awards": 0,
    "timing": "completed",
    "topics": [
      "biotech",
      "oncology",
      "clinical trials",
      "pipeline"
    ],
    "post_id": "1xmz093",
    "summary": "AbbVie discontinued its Phase 2 solid tumor drug livmoniplimab, tested in combination with budigalimab, citing limited clinical benefit.",
    "category": "discontinued",
    "comments": [
      {
        "url": "https://www.reddit.com/r/biotech/comments/1xmz093/comment/19s3hngd3v8rk/",
        "depth": 0,
        "score": 13,
        "author": "Plenty_of_prepotente",
        "excerpt": "From the outside, it looks like AbbVie's oncology strategy needs a rethink. Livmoniplimab, the phase 2 solid tumor drug in the article, was being tested in combination with AbbVie's anti-PD-1 budigalimab, even though as a single agent livmo had an overall response rate in phase 1 of 0%. Why would you keep going after that, assuming you correctly included potentially responsive patients? The biolog",
        "posted_at": "2026-11-03T21:21:58.000Z",
        "author_url": "https://www.reddit.com/user/Plenty_of_prepotente/"
      },
      {
        "url": "https://www.reddit.com/r/biotech/comments/1xmz093/comment/19s3ylez3ul2c/",
        "depth": 0,
        "score": 1,
        "author": "shivaswrath",
        "excerpt": "No wonder their Early pipeline medical role is being moved to Chicago, discovery doesn’t know its ass from its elbow",
        "posted_at": "2026-11-04T03:41:50.000Z",
        "author_url": "https://www.reddit.com/user/shivaswrath/"
      }
    ],
    "evidence": [
      "[post] AbbVie abandons phase 2 solid tumor drug over ‘limited benefit’",
      "[comment u/Plenty_of_prepotente] Livmoniplimab, the phase 2 solid tumor drug in the article, was being tested in combination with AbbVie's anti-PD-1 budigalimab, even though as a single agent livmo had an overall response rate in phase 1 of 0%."
    ],
    "link_url": "https://www.fiercebiotech.com/biotech/abbvie-abandons-phase-2-stage-solid-tumor-drug-over-limited-benefit",
    "virality": "somewhat_high",
    "post_date": "2026-11-03T17:20:36.000Z",
    "post_kind": "link",
    "sentiment": "negative",
    "subreddit": "biotech",
    "event_date": "2026-11",
    "post_flair": [
      "Biotech News 📰"
    ],
    "post_title": "AbbVie abandons phase 2 solid tumor drug over ‘limited benefit’",
    "prominence": "core",
    "source_url": "https://www.reddit.com/r/biotech/comments/1xmz093/abbvie_abandons_phase_2_solid_tumor_drug_over/",
    "entity_role": "subject",
    "post_author": "NotGenentech",
    "upvote_ratio": 1,
    "mention_count": 1,
    "mention_surge": false,
    "subreddit_url": "https://www.reddit.com/r/biotech/",
    "total_upvotes": 49,
    "comments_total": 14,
    "total_comments": 14,
    "post_author_url": "https://www.reddit.com/user/NotGenentech/",
    "signal_category": "event",
    "comments_included": 2,
    "products_mentioned": [
      "livmoniplimab",
      "budigalimab"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.